STRATA CRITICAL MEDICAL, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.88 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 15.88M shares, a 44.25% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 24.08M shares, a 15.82% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 29.40M shares, a 4.57% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 28.49M shares, a 8.52% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 28.53M shares, a 0.18% decline from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 28.58M shares, a 7.26% increase from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 26.64M shares, a 8.87% decline from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 29.24M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 15.88M shares 10-Q · filed 2026-08-04 | 15.88M shares 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | 24.08M shares 10-Q · filed 2026-05-06 | ||||
| 2025-12-31 | 28.53M shares 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | 29.40M shares 10-Q · filed 2025-11-10 | 29.40M shares 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 28.49M shares 10-Q · filed 2026-08-04 | 28.49M shares 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | 28.60M shares 10-Q · filed 2026-05-06 | ||||
| 2024-12-31 | 28.58M shares 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | 30.81M shares 10-Q · filed 2025-11-10 | 30.81M shares 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | 31.15M shares 10-Q · filed 2025-08-05 | 31.15M shares 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | 32.34M shares 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | 26.64M shares 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | 19.45M shares 10-Q · filed 2024-11-12 | 27.53M shares 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 28.25M shares 10-Q · filed 2024-08-08 | 28.25M shares 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | 28.93M shares 10-Q · filed 2024-05-07 | ||||
| 2022-12-31 | 29.24M shares 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | 24.15M shares 10-Q · filed 2023-11-08 | 24.15M shares 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | 15.22M shares 10-Q · filed 2023-08-09 | 24.17M shares 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | 24.61M shares 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | 14.20M shares 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | 25.28M shares 10-Q · filed 2022-11-10 | 25.28M shares 10-K · filed 2023-03-16 | 25.28M shares 10-K · filed 2021-12-20 | ||
| 2021-06-30 | 24.56M shares 10-Q · filed 2022-08-09 | 24.56M shares 10-Q · filed 2022-08-09 | 24.56M shares 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | 9.70M shares 10-Q · filed 2022-05-10 | 14.17M shares 10-Q · filed 2021-05-24 | |||
| 2020-12-31 | 9.75M shares 8-K · filed 2023-01-10 | 14.17M shares 10-K/A · filed 2021-05-07 | |||
| 2020-09-30 | 14.17M shares 10-Q · filed 2020-11-10 | 9.86M shares 10-K · filed 2021-12-20 | |||
| 2020-06-30 | 14.17M shares 10-Q · filed 2020-08-13 | 8.49M shares 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | 14.17M shares 10-Q · filed 2020-05-13 | ||||
| 2019-12-31 | 14.17M shares 10-K · filed 2020-03-20 | ||||
| 2019-09-30 | 14.17M shares 10-Q · filed 2019-11-13 | 8.58M shares 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |